United States · FDA National Drug Code directory
Daptomycin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 60505-6229_bd835d4b-9824-4797-9df1-8237d3b6fca1
- Product NDC
- 60505-6229
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Composition / generic term
- Daptomycin
- Labeler
- APOTEX CORP.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20220223
- Source listing expiry
- 20261231
Source-listed ingredients
- DAPTOMYCIN — 500 mg/10mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, SINGLE-USE in 1 CARTON (60505-6229-4) / 10 mL in 1 VIAL, SINGLE-USE · 60505-6229-4
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →